feed,title,long_url,short_url
Benzinga,Alnylam' Reveals Detailed 18-Month Data From Vutrisiran Trial In Inherited Disease,https://benzinga.com/general/biotech/22/01/25157482/alnylam-reveals-detailed-18-month-data-from-vutrisiran-trial-in-inherited-disease,https://bit.ly/3KwrBV2
Benzinga,Here's Why Wells Fargo Bumped Up Apple's Price Target By 24%,https://benzinga.com/analyst-ratings/analyst-color/22/01/25155932/heres-why-wells-fargo-bumped-up-apples-price-target-by-24,https://bit.ly/3FQc7rt
